全文获取类型
收费全文 | 4189篇 |
免费 | 363篇 |
国内免费 | 105篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 106篇 |
妇产科学 | 121篇 |
基础医学 | 420篇 |
口腔科学 | 66篇 |
临床医学 | 423篇 |
内科学 | 1150篇 |
皮肤病学 | 37篇 |
神经病学 | 218篇 |
特种医学 | 238篇 |
外科学 | 507篇 |
综合类 | 114篇 |
一般理论 | 5篇 |
预防医学 | 294篇 |
眼科学 | 29篇 |
药学 | 246篇 |
中国医学 | 2篇 |
肿瘤学 | 655篇 |
出版年
2022年 | 21篇 |
2021年 | 55篇 |
2020年 | 57篇 |
2019年 | 79篇 |
2018年 | 78篇 |
2017年 | 69篇 |
2016年 | 73篇 |
2015年 | 90篇 |
2014年 | 102篇 |
2013年 | 145篇 |
2012年 | 210篇 |
2011年 | 212篇 |
2010年 | 132篇 |
2009年 | 138篇 |
2008年 | 201篇 |
2007年 | 289篇 |
2006年 | 250篇 |
2005年 | 211篇 |
2004年 | 225篇 |
2003年 | 221篇 |
2002年 | 177篇 |
2001年 | 104篇 |
2000年 | 99篇 |
1999年 | 80篇 |
1998年 | 74篇 |
1997年 | 60篇 |
1996年 | 70篇 |
1995年 | 45篇 |
1994年 | 45篇 |
1993年 | 33篇 |
1992年 | 54篇 |
1991年 | 51篇 |
1990年 | 69篇 |
1989年 | 76篇 |
1988年 | 59篇 |
1987年 | 64篇 |
1986年 | 63篇 |
1985年 | 43篇 |
1984年 | 34篇 |
1983年 | 26篇 |
1982年 | 32篇 |
1981年 | 26篇 |
1980年 | 29篇 |
1979年 | 26篇 |
1977年 | 33篇 |
1976年 | 25篇 |
1973年 | 19篇 |
1972年 | 18篇 |
1971年 | 27篇 |
1970年 | 31篇 |
排序方式: 共有4657条查询结果,搜索用时 15 毫秒
1.
Background
Total knee arthroplasty is a treatment option for debilitating arthritis. In the postoperative period, patients experience moderate to severe pain affecting the rehabilitation, hospital stay, and patient satisfaction. This study aims at utilizing current best evidence to determine whether adductor canal block (ACB) or periarticular injection (PAI) is a better modality for managing short-term postoperative pain and opioid consumption.Methods
Embase, MEDLINE, HealthStar, Emcare, and PubMed were searched for randomized controlled trials from 1946 to August 2018, for literature addressing the comparison of ACB and PAI for pain management in the setting of total knee arthroplasty. A systematic review and meta-analysis were performed.Results
Six studies were included in our meta-analysis. When examining the combined visual analog scale (VAS) pain values for each group, analysis demonstrated greater reduction in scores for the PAI group, and the difference was statistically significant (P = .001). When comparing the VAS scores of subgroups analyzed at specific periods in time, there was a trend toward lower VAS scores in subgroups analyzed at 24 hours and 48 hours postoperatively (at rest and at movement) in the PAI group. Overall opioid consumption was lower in the PAI group, with demonstrated statistical significance (P = .03). When comparing the postoperative subgroups, there was a trend toward decreased opioid use in the PAI group, with 13.25% less opioid use at 48 hours and 9.5% less opioid use at 24 hours.Conclusion
PAI could significantly improve postoperative pain and opioid consumption when compared with ACB. Additional, high-quality studies are required to further address this topic. 相似文献2.
Nishard Abdeen Albert Cross Gregory Cron Steven White Thomas Rand David Miller Giles Santyr 《Magnetic resonance in medicine》2006,56(2):255-264
We used the dual capability of hyperpolarized 129Xe for spectroscopy and imaging to develop new measures of xenon diffusing capacity in the rat lung that (analogously to the diffusing capacity of carbon monoxide or DLCO) are calculated as a product of total lung volume and gas transfer rate constants divided by the pressure gradient. Under conditions of known constant pressure breath-hold, the volume is measured by hyperpolarized 129Xe MRI, and the transfer rate is measured by dynamic spectroscopy. The new quantities (xenon diffusing capacity in lung parenchyma (DLXeLP)), xenon diffusing capacity in RBCs (DLXeRBC), and total lung xenon diffusing capacity (DLXe)) were measured in six normal rats and six rats with lung inflammation induced by instillation of fungal spores of Stachybotrys chartarum. DLXeLP, DLXeRBC, and DLXe were 56 +/- 10 ml/min/mmHg, 64 +/- 35 ml/min/mmHg, and 29 +/- 9 ml/min/mmHg, respectively, for normal rats, and 27 +/- 9 ml/min/mmHg, 42 +/- 27 ml/min/mmHg, and 16 +/- 7 ml/min/mmHg, respectively, for diseased rats. Lung volumes and gas transfer times for LP (TtrLP) were 16 +/- 2 ml and 22 +/- 3 ms, respectively, for normal rats and 12 +/- 2 ml and 35 +/- 8 ms, respectively, for diseased rats. Xenon diffusing capacities may be useful for measuring changes in gas exchange associated with inflammation and other lung diseases. 相似文献
3.
4.
Chris Giles 《Canadian Medical Association journal》2002,167(7):786-787
5.
6.
7.
CM Reid M. Nelson P. Beckinsale P. Ryan LMH Wing LJ Beilin MA Brown GLR Jennings CI Johnston J. Marley JJ McNeil TO Morgan J. Shaw ID Steven MJ West 《Clinical and experimental pharmacology & physiology》1997,24(5):370-373
1. The present study aimed to determine the feasibility of conducting a 5 year cardiovascular outcome trial of the treatment of 6000 elderly hypertensive patients in Australian general practices. 2. General practitioners (GPs) were invited to participate by mail and personal follow-up. Patient records were reviewed to identify subjects for a blood pressure (BP) screening programme. Blood pressure was measured on three occasions and eligible subjects were included if the average BP was 160 mmHg systolic or 90 mmHg diastolic if systolic BP was 140 mmHg. 3. Seven hundred and forty-one GPs were approached and 89 were enrolled in the study (12% of mail invites and 75% of those receiving a personal contact). In 16 practices where screening was completed, 82 000 records were reviewed to identify 4% patients eligible for screening. Twenty-two per cent of eligible subjects attended screening. Of 1938 subjects screened, 180 (9%) had BP 5=160/90 mmHg. Forty-seven percent of subjects (n = 916) were receiving antihypertensive therapy and 184 (20%) were withdrawn from therapy. One hundred and sixteen (63%) of these subjects had BP return to study entry levels within 6 weeks. Fifty-seven newly diagnosed and 81 previously treated subjects were randomized (7% of the screened population). 4. Based on the high participation rate of GPs, the response rate of patients to attend a BP screening programme and the 7% randomization to screening ratio for entry into the study, the ANBP2 pilot study has demonstrated that it is feasible to recruit subjects from Australian general practices to a cardiovascular outcome trial. 相似文献
8.
Intravenous captopril in congestive heart failure 总被引:1,自引:0,他引:1
S Ahmad T D Giles L E Roffidal Y Haney M B Given G E Sander 《Journal of clinical pharmacology》1990,30(7):609-614
Hemodynamic and neurohumoral effects of intravenous captopril were studied in ten patients with severe chronic congestive heart failure (NYHA Functional Class III and IV). Incremental bolus doses of captopril, titrated to a maximum cumulative dose of 15 mg, were given at 10-minute intervals. Systemic arterial pressure, mean pulmonary capillary wedge pressure, systemic vascular resistance, mean pulmonary artery pressure, and heart rate decreased (P less than .05). Cardiac index and stroke volume index increased (P less than .05). Maximum hemodynamic effects occurred after cumulative doses of 7 mg and were seen within 30 minutes after initiation of therapy; responses persisted for 30-90 minutes after the last dose. Plasma renin activity increased, and plasma atrial natriuretic factor concentration decreased. No adverse effects were observed with the use of intravenous captopril. Thus, intravenous captopril produces rapid and favorable hemodynamic improvement in advanced heart failure patients. 相似文献
9.
10.